Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic Advances Its Data Logic Division with New Staff Appointments


BERKELEY, Calif.--Gene Logic filled two key positions last month in its newly expanded and named Data Logic division here. The company also said it has expanded the division's mission to market its suite of data-management and integration tools directly to pharmaceutical companies. The division already develops and deploys Gene Logic's proprietary and custom-built databases for pharmaceutical company partners.

Gene Logic bioinformatics tools are based on the object protocol initially developed by Victor Markowitz at Lawrence Berkeley National Laboratory. Markowitz, who joined Gene Logic last year as vice-president of bioinformatics systems, has been promoted to senior vice-president of Data Logic. In the other appointment, Jim Veitch, formerly of Franz, a supplier of dynamic object-oriented development tools to the computer industry, was named vice-president of business development for the Data Logic Division.

Michael Brennan, Gene Logic's president, said he believes there is a "substantial, independent business opportunity" in the "growing market for comprehensive data management solutions for bioinformatics."

Filed under

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.